Companies: 10,795·Total market cap: $144.5T

Century Therapeutics, Inc.

Century Therapeutics, Inc.

IPSCNASDAQHealthcare● Active

$2.12

$-0.01(-0.47%)

Market Cap$183527105

P/E Ratio—

52W High$3.04

52W Low$0.435

Avg Volume1.2M

Open$2.13

Beta1.57

Net Income Financials Revenue

Century Therapeutics, Inc. (IPSC) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

IPSC · net income · updated Jun 9, 2026

Core profitability metrics

IPSC · net income · margin · TTM · CAGR

Net income was −$9.6M for FY2025 (fiscal year ending 2025-12-31), up 92.4% year-over-year. Net profit margin was -8.8%.

FY2025 Net Income−$9.6M▲ +92.4% YoY

Trailing 12M (TTM)−$107.8Mtrailing 4 quarters sum

Net Profit Margin-8.8%−$9.6M ÷ $109.2M

YoY Change+92.4%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · IPSC net income history · IPSC profit margin

Annual net income data

IPSC · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$9.6M▲ +92.4%-8.8%$109.2M

FY2024Loss−$126.6M▲ +7.4%-1920.9%$6.6M

FY2023Loss−$136.7M▼ 4.4%-6115.1%$2.2M

FY2022Loss−$130.9M▼ 36.6%-2518.4%$5.2M

FY2021Loss−$95.8M▼ 78.9%—$0

Net income vs peers (Healthcare)

IPSC vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Century Therapeutics, Inc.YOU

IPSC

−$9.6M+92.4%-8.8%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Century Therapeutics, Inc. (IPSC) reported net income of −$9.6M for FY2025 (fiscal year ending 2025-12-31), up 92.4% year-over-year. The net profit margin was -8.8% — meaning the company kept $-0.09 of every dollar of revenue as profit.

Century Therapeutics, Inc. has not yet achieved annual profitability based on available data (7 fiscal years). The company has reported net losses across all available periods.

Century Therapeutics, Inc.'s net profit margin was -8.8% for FY2025, based on the latest annual results.

Investors sometimes search for "Century Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from IPSC net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

IPSC net income · 4 questions

Century Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $9.6M for FY2025.

is IPSC profitabledoes IPSC make a profitIPSC profitabilityIPSC profitable company

▸ Source: FMP /income-statement · GAAP · Century Therapeutics, Inc. · Century Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026